Retraction

MicroRNA‑425 is downregulated in nasopharyngeal carcinoma and regulates tumor cell viability and invasion by targeting hepatoma‑derived growth factor

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.3892/ol.2024.14245
Additional Notes:

see also: https://pubpeer.com/publications/C519FEC25F4EB5DC09577338557F97

Citations (19)

19
Total Citations
0
Post-Retraction
19
Pre-Retraction
0
Same Day
Diverse Functions of MiR-425 in Human Cancer
Zhichao Wang, Wenjie Xie, Hongzai Guan
DNA and Cell Biology
Published: Feb 2023
4 citations
340 days before retraction
Biomechanics Research on microRNA-223 Expression Activated the Phosphatidylinositol-3-Kinase/Protein Kinase B Pathway by Biotically Methylating the Long Noncoding RNA KCNQ1OT1
Xue Bian, Xiaojie Liang, Ying Zhang et al. (4 authors)
Indian Journal of Pharmaceutical Sciences Open Access
Published: Jan 2022
751 days before retraction
NAP1L1 targeting suppresses the proliferation of nasopharyngeal carcinoma
Yahui Liu, Xiaoning Li, Yewei Zhang et al. (7 authors)
Biomedicine & Pharmacotherapy Open Access
Published: Sep 2021
16 citations
851 days before retraction
Advances in Research on microRNAs Related to the Invasion and Metastasis of Nasopharyngeal Carcinoma
Shanshan Zhang, Baiqi Wang, Lulu Zheng et al. (7 authors)
Current Molecular Pharmacology
Published: Jun 2021
1 citation
951 days before retraction
miR‐425 regulates ovarian cancer proliferation, metastasis, and apoptosis by repressing PAK4 expression
Yichen Wang, Feng Shao, Lu Chen
Asia-Pacific Journal of Clinical Oncology
Published: Mar 2021
7 citations
1033 days before retraction
MicroRNA-425 induces apoptosis and suppresses migration and invasion of human cervical cancer cells by targeting RAB2B
Yue Tian, Ying Luo, Jing Wang
International Journal of Immunopathology and Pharmacology Open Access
Published: Jan 2021
4 citations
1116 days before retraction
<i>Retracted</i>: Extracellular vesicle‐encapsulated microRNA‐425‐derived from drug‐resistant cells promotes non‐small–cell lung cancer progression through DAPK1‐medicated PI3K/AKT pathway
Zhihua Guo, Huangyang Ye, Xiaobin Zheng et al. (5 authors)
Journal of Cellular Physiology
Published: Nov 2020
4 citations
1148 days before retraction
FOXD3 inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma through regulation of the PI3K–Akt pathway
Xiaoxing Xie, Gaoyun Xiong, Wenjun Chen et al. (6 authors)
Biochemistry and Cell Biology
Published: May 2020
8 citations
1335 days before retraction
Genetics of nasopharyngeal carcinoma and molecular signaling pathways
Murtala Bello Abubakar, Siew Hua Gan
Elsevier eBooks
Published: Jan 2020
1 citation
1482 days before retraction
MicroRNA-425-5p Inhibits Lung Cancer Cell Growth in Vitro and in Vivo by Downregulating TFIIB-Related Factor 2
Xi Yu, Hong Zheng, Rongfei Sun et al. (8 authors)
Technology in Cancer Research & Treatment Open Access
Published: Jan 2020
4 citations
1482 days before retraction
Potential Relationship between Clinical Significance and Serum Exosomal miRNAs in Patients with Multiple Myeloma
Zhiyao Zhang, Yanchen Li, Chuanying Geng et al. (5 authors)
BioMed Research International Open Access
Published: Dec 2019
25 citations
1500 days before retraction
miR-425-5p suppresses tumorigenesis and DDP resistance in human-prostate cancer by targeting GSK3β and inactivating the Wnt/β-catenin signaling pathway
Sheng Liu, Qin Wang, Yin Liu et al. (4 authors)
Journal of Biosciences
Published: Aug 2019
31 citations
1627 days before retraction
miR‑425‑5p promotes cell proliferation, migration and invasion by directly targeting FOXD3 in hepatocellular carcinoma cells
Hewen Wu, Jia Shang, Weili Zhan et al. (6 authors)
Molecular Medicine Reports Open Access
Published: Jun 2019
13 citations
1671 days before retraction
miR-429 suppresses cell proliferation, migration and invasion in nasopharyngeal carcinoma by downregulation of TLN1
Zhihui Wang, Zhiquan Zhu, Lin Zhong et al. (8 authors)
Cancer Cell International Open Access
Published: Apr 2019
25 citations
1728 days before retraction
miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt/β-catenin signaling pathway
Guohui Yang, Chi Zhang, Nan Wang et al. (4 authors)
The International Journal of Biochemistry & Cell Biology
Published: Apr 2019
38 citations
1746 days before retraction
MicroRNA-425 controls lipogenesis and lipolysis in adipocytes
Renli Qi, Jing Wang, Qi Wang et al. (7 authors)
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids Open Access
Published: Feb 2019
37 citations
1791 days before retraction
miR-425 suppresses EMT and the development of TNBC (triple-negative breast cancer) by targeting the TGF-β 1/SMAD 3 signaling pathway
Yingping Liu, Jinglong Chen
RSC Advances Open Access
Published: Dec 2018
15 citations
1858 days before retraction
miR-425 suppresses EMT and inhibits the development of TNBC (triple-negative breast cancer) by targeting TGF-β 1/SMAD 3 signaling pathway
Yingping Liu, Hongfei Qiao, Jinglong Chen
bioRxiv (Cold Spring Harbor Laboratory) Open Access
Published: Nov 2018
1883 days before retraction
The regulatory network of nasopharyngeal carcinoma metastasis with a focus on EBV, lncRNAs and miRNAs.
Chen-Xuan Zhao, Wei Zhu, Zhengqing Ba et al. (10 authors)
PubMed
Published: Jan 2018
40 citations
2212 days before retraction
Quick Stats
Total Citations: 19
Years Since Retraction: 1.8 year
Open Access: Yes
Last Checked: Jul 24, 2025